Amyloglucosidase Activators encompass a range of chemical compounds that indirectly augment its functional activity by modulating various biochemical pathways related to carbohydrate metabolism. Acarbose, Miglitol, Voglibose, and similar alpha-glucosidase inhibitors like Deoxynojirimycin and 1-Deoxynojirimycin play a crucial role in this process. These inhibitors target competitive enzymes, reducing their activity, which could result in increased substrate availability for Amyloglucosidase. This indirect enhancement is significant as it leads to a potentially higher functional demand for Amyloglucosidase in glycogen breakdown and glucose metabolism. Furthermore, compounds such as Isoquercetin and Genistein, known for their effects on glucose metabolism and tyrosine kinase inhibition, respectively, also contribute to this increased demand. Their influence on cellular signaling pathways could lead to altered dynamics in glycogenolysis, subsequently increasing the functional role of Amyloglucosidase. Additionally, the presence of specific substrates or analogs like Salicin and Glycyrrhizin, known for their interaction with glucosidases, may further boost the activity of Amyloglucosidase by providing additional substrates, thus potentially enhancing the enzyme's turnover rate.
The intricate balance of glucose and carbohydrate metabolism is further influenced by compounds that interact with glucose transport and metabolism, like Phlorizin and Castanospermine. Phlorizin's role as a competitive inhibitor of glucose transporters could lead to changes in intracellular glucose levels, indirectly influencing the functional necessity for Amyloglucosidase in carbohydrate metabolism pathways. Castanospermine, with its indolizidine alkaloid structure, inhibits other glucosidases, potentially reducing enzymatic competition for substrates, thereby favoring Amyloglucosidase activity. The presence of 4-Methylumbelliferyl glucoside, a fluorescent substrate for glucosidases, also plays a unique role. Its utilization by Amylogloglucosidase not only aids in the measurement of the enzyme's activity but also signifies an increased turnover of the enzyme when this substrate is abundant. This turnover is a crucial indicator of enhanced functional activity of Amyloglucosidase. Collectively, these activators, through their targeted effects on carbohydrate metabolism and related pathways, facilitate the enhancement of Amyloglucosidase activity. They achieve this by creating an environment where the enzyme's substrates are more readily available, the competitive enzymatic activities are reduced, and the overall metabolic pathways are aligned to increase the functional demand for Amyloglucosidase.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Acarbose | 56180-94-0 | sc-203492 sc-203492A | 1 g 5 g | $226.00 $605.00 | 1 | |
Acarbose, an alpha-glucosidase inhibitor, indirectly enhances Amyloglucosidase activity by inhibiting competitive enzymes in carbohydrate metabolism, thus potentially increasing substrate availability for Amyloglucosidase. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Castanospermine, an indolizidine alkaloid, inhibits other glucosidases, potentially reducing competition and indirectly enhancing the activity of Amyloglucosidase by making more substrates available for its action. | ||||||
Deoxynojirimycin | 19130-96-2 | sc-201369 sc-201369A | 1 mg 5 mg | $73.00 $145.00 | ||
Deoxynojirimycin, an iminosugar, inhibits alpha-glucosidases. By inhibiting competing enzymes in carbohydrate metabolism, it could indirectly lead to increased substrate availability and hence, enhanced activity for Amyloglucosidase. | ||||||
Miglitol | 72432-03-2 | sc-221943 | 10 mg | $161.00 | 1 | |
Miglitol, another alpha-glucosidase inhibitor, functions similarly to Acarbose and Deoxynojirimycin, potentially enhancing Amyloglucosidase activity by reducing competition for glucosidic substrates. | ||||||
Voglibose | 83480-29-9 | sc-204384 sc-204384A | 10 mg 50 mg | $198.00 $681.00 | ||
Voglibose acts as an alpha-glucosidase inhibitor. By inhibiting enzymes that compete with Amyloglucosidase for substrates, it could indirectly lead to an increased functional demand and activity for Amyloglucosidase. | ||||||
D-(−)-Salicin | 138-52-3 | sc-218004 | 5 g | $59.00 | ||
Salicin, a glucoside, can be a substrate for glucosidases. Its presence may enhance Amyloglucosidase activity by providing additional substrate, thereby potentially increasing the enzyme's functional turnover. | ||||||